Table 2 Effect of statin use on the incidence of gastric cancer in diabetic patients
From: Statins and the risk of gastric cancer in diabetes patients
Univariable analysis | ||||
|---|---|---|---|---|
Variables | Case | Control | P-value | OR(95% CI) |
Statin use | 99 | 367 | < .0001 | 0.183 (0.139 – 0.241) |
Aspirin | 184 | 347 | < .0001 | 0.418 (0.337 – 0.518) |
Other lipid lowering agents | 154 | 221 | < .0001 | 0.148 (0.073 – 0.297) |
Multivariable analysis | ||||
Variable | Case | Control | P-value | OR (95% CI) |
Statin use | 99 | 367 | < .0001 | 0.211 (0.159 – 0.281) |
Aspirin | 184 | 347 | < .0001 | 0.608 (0.478 – 0.773) |
Other lipid lowering agents | 154 | 221 | < .0001 | 0.156 (0.073 – 0.337) |